News

Glow Lifetech Announces Commencement of Clinical Study of Artemic Support® Featuring MyCell® Technology on Patients with Long COVID

Glow Completes Buildout of Canadian Facility and Begins Commissioning Proprietary Reactor

Glow Engages Regulatory Consultant Firms to Advance Commercialization of Artemic™ and Other Nutraceutical Ingredients in U.S. and Mexico

Glow Takes Receipt of MyCell® Reactor for Prototyping and Formulation for Canadian Processing; Receives CSA Standards Approval

Glow Lifetech Strengthens Management Team with Manufacturing and Product Development Leaders; Provides Management Overview

Glow LifeTech Announces Upgrade to OTCQB Under Ticker ‘GLWLF’

Glow Acquires Strategic Equity Investment in Nova Mentis

Glow LifeTech Secures Canadian Processing Facility; Begins Build-out to Produce Next-Generation Cannabis Ingredients